Showing results (911-920 of 925) with videos related to
Sort By:
Pageof 93
Molecular Cell|June 7, 2020
Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 LocusMarco Mineo, Shawn M Lyons, Mykola Zdioruk, et al.Haematologica|September 17, 2013
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-ISrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.The New England Journal of Medicine|March 2, 2012
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosisSrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.Molecules (Basel, Switzerland)|August 12, 2022
Correlating Sensory Assessment of Smoke-Tainted Wines with Inter-Laboratory Study Consensus Values for Volatile PhenolsJames W Favell, Kerry L Wilkinson, Ieva Zigg, et al.Nucleic Acids Research|July 2, 2025
Elucidating brain transport pathways and cell type-dependent gene silencing of a durable lipid-siRNA conjugate administered into cerebrospinal fluidAlexander G Sorets, Katrina R Schwensen, Nora Francini, et al.Nature Communications|August 23, 2017
Platelets reduce anoikis and promote metastasis by activating YAP1 signalingMonika Haemmerle, Morgan L Taylor, Tony Gutschner, et al.Journal of Crohn'S & Colitis|February 16, 2019
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab CohortN Plevris, C S Chuah, R M Allen, et al.Nature Medicine|January 12, 2021
Modeling human adaptive immune responses with tonsil organoidsLisa E Wagar, Ameen Salahudeen, Christian M Constantz, et al.Haematologica|August 6, 2013
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studiesRuben A Mesa, Jean-Jacques Kiladjian, Srdan Verstovsek, et al.Lancet (London, England)|February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J Kuter, James B Bussel, Roger M Lyons, et al.Pageof 93